Greg Dwyer

Company: Orum Therapeutics

Job title: Vice President, Head of Business Development

Seminars:

Uncovering Protein Homeostasis by Dual Precision Approach & Development of a Novel Catalytic Payload Class With an Improved Safety and Efficacy Profile & Exploring Diversity of degrader SAR 9:30 am

Development of a novel, catalytic payload class leveraging catalytic enzmes to disrupt cellular processes Exploring the diversity of degrader SAR studies while also enabling conjugation to targeting format Improving potency and selectivity of delivery to target cells with catalytic action allowing for lower payload dosesRead more

day: Conference Day Two